A carregar...

Cost effectiveness of combination therapy for hepatitis C: a decision analytic model

Objective: To estimate the cost utility of treatment with combination therapy (ribavirin and interferon α) for hepatitis C compared with no treatment or monotherapy (interferon α) based on UK costs and clinical management. Design: Decision analysis model using a Markov approach to simulate disease p...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Stein, K, Rosenberg, W, Wong, J
Formato: Artigo
Idioma:Inglês
Publicado em: Copyright 2002 by Gut 2002
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1773115/
https://ncbi.nlm.nih.gov/pubmed/11788569
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!